ALK inhibitors downregulate the expression of death receptor 4 in ALK-mutant lung cancer cells via facilitating Fra-1 and c-Jun degradation and subsequent AP-1 suppression
- Resource Type
- Article
- Source
- In
Neoplasia August 2023 42 - Subject
- Language
- ISSN
- 1476-5586